Liquidia Corp. (LQDA) is scheduled to present clinical data from its ASCENT trial at the CHEST 2025 Annual Meeting on October 21, 2025.
The CHEST Annual meeting, hosted by the American College of Chest Physicians, is a yearly gathering of pulmonologists, critical care physicians, respiratory therapists, and other chest medicine professionals to exchange advances in diagnosis, treatment, and patient care.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com